Skip to content
Screener

Innoviva, Inc. INVA Q3 2025 earnings

Reported November 5, 2025 · Before market open

Revenue$107.8MBeat by $6.3M
EPS$1.08Beat by $0.62
Revenue estimate$101.5M
EPS estimate$0.46

Next report

Nov 4, 2026 (in a month)
Revenue estimate$115.3M
EPS estimate$0.49

Financials

Q3 2025

Income statement

See full
Revenue$107.8M+20.4%
Gross profit$75.5M+3.5%
Operating income$34.6M-20.0%
Net income$89.9M+7,312%
EPS (diluted)$1.08+5,300%

Balance sheet

See full
Cash & equivalents$476.5M+82.8%
Total debt$259.0M-42.6%
Total assets$1.4B+16.0%

Cash flow

See full
Operating cash flow$49.7M+2.1%
CapEx$1.1M+315%
Free cash flow$48.6M+0.4%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.15B-4.8%
Enterprise value$932.58M-33.3%
P/E9×-9.7×
P/S3×-0.5×

Profitability

See full
Gross margin79.8%+0.6pp
Operating margin43.2%+0.1pp
Net margin32.8%+14.5pp
FCF margin51.6%+5.6pp

Returns & leverage

See full
Current ratio14.1×+12.3×

Segments

By product

See full
Giapreza$18.5M+34.0%
Cost Reimbursement$1.3M—

FAQ

When did Innoviva, Inc. report Q3 2025 earnings?
Innoviva, Inc. (INVA) reported Q3 2025 earnings on November 5, 2025 before market open.
What were Innoviva, Inc.'s Q3 2025 revenue and EPS?
Innoviva, Inc. reported revenue of $107.8M and eps of $1.08 for Q3 2025.
Did Innoviva, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $101.5M by $6.3M. EPS beat the consensus estimate of $0.46 by $0.62.
How did Innoviva, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 20.4% from $89.5M a year earlier and eps grew 5300.0% from $0.02.
Where can I find Innoviva, Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-107014) and the 10-Q periodic report (0001193125-25-267040) directly on SEC EDGAR. The filing index links above go to sec.gov.